MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 59 filers reported holding MENLO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $9,411,000 | -78.1% | 5,440 | -66.1% | 0.00% | – |
Q1 2020 | $42,987,000 | +147.3% | 16,040 | +328.1% | 0.00% | – |
Q4 2019 | $17,386,000 | +101.9% | 3,747 | +95.0% | 0.00% | – |
Q3 2019 | $8,611,000 | -24.5% | 1,922 | +1.0% | 0.00% | – |
Q2 2019 | $11,399,000 | -31.1% | 1,903 | -9.7% | 0.00% | – |
Q1 2019 | $16,540,000 | +956.2% | 2,107 | +454.5% | 0.00% | – |
Q4 2018 | $1,566,000 | -21.3% | 380 | +88.1% | 0.00% | – |
Q3 2018 | $1,990,000 | +4.3% | 202 | -14.0% | 0.00% | – |
Q2 2018 | $1,908,000 | -95.6% | 235 | -79.6% | 0.00% | – |
Q1 2018 | $43,292,000 | – | 1,152 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 4,359,030 | $7,541,000 | 8.27% |
Healthcare Value Capital, LLC | 1,700,000 | $2,941,000 | 7.51% |
683 Capital Management, LLC | 5,550,208 | $9,602,000 | 0.77% |
Perceptive Advisors | 22,876,410 | $39,576,000 | 0.64% |
Vivo Capital, LLC | 3,643,824 | $6,304,000 | 0.45% |
Monashee Investment Management LLC | 1,005,000 | $1,739,000 | 0.26% |
MYDA Advisors LLC | 93,300 | $161,000 | 0.10% |
Sofinnova Investments, Inc. | 725,571 | $1,256,000 | 0.08% |
CAAS CAPITAL MANAGEMENT LP | 1,185,501 | $2,051,000 | 0.07% |
Grace Capital | 36,012 | $62,000 | 0.05% |